ArticleJournal of clinical medicine2025

Ixazomib-Lenalidomide-Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: A Hungarian Real-World Analysis.

Hermina Sánta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.